摘要:
The use of VR4 polypeptides and polynucleotides in the design of protocols for the treatment of diseases of cartilage, such as hyaline-, fibro- and elastic-cartilage, or diseases of tissues where such cartilage is found including diseases or disorders affecting the larynx, auditory canal, intervertebral discs, ligaments, tendons and joint capsules, bone development including osteoporosis, diseases involving joint destruction and also pain linked to rheumatoid arthritis and osteoarthritis.